AMT-253

News alerts, weekly reports and conference planners

Company:

Suzhou Maximum Bio-tech

Drug class:

CAR-T immunotherapy

Related drugs:

MCAM expression	Solid Tumor	MCAM expression	Solid Tumor	AMT-253 Sensitive: D – Preclinical AMT-253 Sensitive : D	AMT-253 Sensitive: D – Preclinical AMT-253 Sensitive : D
MCAM expression	Melanoma	MCAM expression	Melanoma	AMT-253 Sensitive: D – Preclinical AMT-253 Sensitive : D	AMT-253 Sensitive: D – Preclinical AMT-253 Sensitive : D

Associations
(2)